Apply to trial NCT06793059

A few quick questions so the study team can decide if you might be a fit.

RecruitingDevice study

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening